Sughrue Mion, PLLC
Method for treating cancer using an interferon alpha conjugate
A method for preventing or treating a cancer includes administering an anti-cancer pharmaceutical composition including an interferon alpha or a polymer conjugate thereof. The pharmaceutical composition can be co-administered with anti-cancer agents. The interferon alpha conjugate shows a longer in vivo half-life and a more excellent anti-cancer activity than the conventional interferon alpha, and in particular, its co-administration with an anti-cancer agent such as gemcitabine has synergistic inhibitory effects on cancer cell growth and proliferation so as to exhibit a remarkably excellent anti-cancer activity. Further, the anti-cancer pharmaceutical composition has excellent in vivo half-life and anti-cancer activity to greatly reduce administration frequency. Co-administration of an anti-cancer agent and the interferon alpha conjugate having excellent anti-cancer activity reduces administration dose of anti-cancer agent so as to reduce side effects of anti-cancer agent and increase treatment compliance of patient.
BEIJING HANMI PHARMACEUTICAL CO., LTD. HANMI SCIENCE CO., LTD.
A A A A A A A A
A61P A61K A61P A61K A61K A61K A61K A61K
inventional inventional inventional inventional inventional inventional inventional inventional
Sung Youb Se Young Se Chang Jae Ho In Young Sung Hwan Jiawang Young Eun
Jung Lim Kwon Lee Choi Moon Liu Woo